Advertisement

Annals of Surgical Oncology

, Volume 22, Issue 13, pp 4363–4370 | Cite as

The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?

  • Eun Young Kim
  • Jin Won Lee
  • Han Mo Yoo
  • Cho Hyun Park
  • Kyo Young Song
Gastrointestinal Oncology

Abstract

Background

As indicators of the systemic inflammatory response, the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) have been proposed to predict the clinical outcome in some cancers. The purpose of this study was to investigate the impact of NLR and PLR on the prognosis of gastric cancer.

Methods

From 2000 to 2009, 1986 consecutive patients who underwent curative surgery for gastric cancer were enrolled. The optimal cutoff value of PLR and NLR was determined according to receiver operating characteristic analysis. We categorized the patients into the high or low PLR and NLR group based on the cutoff value, and the clinical features of these two groups were comparatively analyzed.

Results

The high NLR and PLR groups were significantly associated with poor prognosis. The NLR was an independent prognostic factor for overall survival [hazard ratio (HR) = 1.403; p = 0.023]; however, the PLR was not (p = 0.788).

Conclusions

Although both the PLR and NLR can reflect the prognosis, the NLR is more predictive of overall survival than the PLR.

Keywords

Gastric Cancer Overall Survival Early Gastric Cancer Laparoscopic Gastrectomy Remnant Gastric Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgment

The authors are grateful for the statistics related consultation provided by the Catholic Research Coordinating Center’s Department of Biostatistics and also thank Hyun Kyo Kim for collection and assembly of data.

Disclosure

No disclosure of any commercial, financial, or material support.

References

  1. 1.
    Azab B, Shah N, Radbel J, et al. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol. 2013;30(1):432.CrossRefPubMedGoogle Scholar
  2. 2.
    He W, Yin C, Guo G, et al. Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer. Med Oncol. 2013;30(1):439.CrossRefPubMedGoogle Scholar
  3. 3.
    Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dagg K, Scott HR. A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2005;92(10):1834–6.PubMedCentralCrossRefPubMedGoogle Scholar
  4. 4.
    Smith RA, Bosonnet L, Ghaneh P, et al. The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. Surgery. 2008;143(5):658–66.CrossRefPubMedGoogle Scholar
  5. 5.
    Nozoe T, Ninomiya M, Maeda T, Matsukuma A, Nakashima H, Ezaki T. Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma. Surg Today. 2010;40(5):440–3.CrossRefPubMedGoogle Scholar
  6. 6.
    Kasymjanova G, MacDonald N, Agulnik JS, et al. The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol. 2010;17(4):52–8.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Brigati C, Noonan DM, Albini A, Benelli R. Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis. 2002;19(3):247–58.CrossRefPubMedGoogle Scholar
  8. 8.
    Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–45.CrossRefPubMedGoogle Scholar
  9. 9.
    Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–7.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Ikeda M, Furukawa H, Imamura H, et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol. 2002;9(3):287–91.CrossRefPubMedGoogle Scholar
  11. 11.
    Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost. 2011;9(2):237–49.CrossRefPubMedGoogle Scholar
  12. 12.
    Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137–48.CrossRefPubMedGoogle Scholar
  13. 13.
    De Larco JE, Wuertz BR, Furcht LT. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res. 2004;10(15):4895–900.CrossRefPubMedGoogle Scholar
  14. 14.
    Takahashi R, Mabuchi S, Kawano M, et al. Prognostic significance of systemic neutrophil and leukocyte alterations in surgically treated endometrial cancer patients: a monoinstitutional study. Gynecol Oncol. 2015. doi: 10.1016/j.ygyno.2015.02.006.Google Scholar
  15. 15.
    Qiu MZ, Xu RH, Ruan DY, et al. Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China. Tumour Biol. 2010;31(6):633–41.CrossRefPubMedGoogle Scholar
  16. 16.
    Aurello P, Tierno SM, Berardi G, et al. Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer. Ann Surg Oncol. 2014;21(6):1998–2004.CrossRefPubMedGoogle Scholar
  17. 17.
    Mano Y, Shirabe K, Yamashita Y, et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 2013;258(2):301–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Malietzis G, Giacometti M, Askari A, et al. A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Ann Surg. 2014;260(2):287–92.CrossRefPubMedGoogle Scholar
  19. 19.
    Jung MR, Park YK, Jeong O, et al. Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol. 2011;104(5):504–10.CrossRefPubMedGoogle Scholar
  20. 20.
    Lee S, Oh SY, Kim SH, et al. Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy. BMC Cancer. 2013;13:350.PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Jiang N, Deng JY, Liu Y, Ke B, Liu HG, Liang H. The role of preoperative neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after radical resection for gastric cancer. Biomarkers. 2014;19(6):444–51.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2015

Authors and Affiliations

  • Eun Young Kim
    • 1
  • Jin Won Lee
    • 1
  • Han Mo Yoo
    • 1
  • Cho Hyun Park
    • 1
  • Kyo Young Song
    • 1
  1. 1.Division of Gastrointestinal Surgery, Department of Surgery, College of Medicine, Seoul St. Mary’s HospitalThe Catholic University of KoreaSeoulKorea

Personalised recommendations